CAPITAL PRO-ÉGAUX INC., THROUGH ITS WHOLLY OWNED SUBSIDIARY TECHNIQUE
D'USINAGE SINLAB INC, HAS RECEIVED COURT ACTIONS FILED BY NOBEL BIOCARE IN
GERMANY AND ITALY

LACHENAIE, QC, Aug. 26 /CNW Telbec/ - Capital Pro-Égaux Inc. (the "Company") reports that it's wholly owned subsidiary Technique d'usinage Sinlab Inc., has received translated court actions from Nobel Biocare to attempt to nullify the company German and Italian superstructure patent1,043,960 issued September 3rd of 2003.

These procedures are filed by Nobel Biocare subsequently to a COURT ACTION   filed on June 25th, 2010 by Technique d'usinage Sinlab Inc against BioCad Medical Inc, a Québec city based company wholly owned by Nobel Biocare, for patent infringement of the Company Canadian patent 2,575,964 issued on 27th of May 2008.

About Pro-Égaux Inc.

Pro-Égaux through its wholly owned subsidiary, Technique d'usinage Sinlab Inc., is a company based in Lachenaie, Quebec, specializing mainly in the conception and design of titanium products to be used in the dental prosthesis restoration industry.

"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."

SOURCE Capital Pro-Égaux Inc.

For further information: For further information:

Capital Pro-Égaux Inc.
Pierre Désormeau
President
Tel.: (514) 616-0612
Fax: (450) 226-1923
pierredesormeau@sympatico.ca

Organization Profile

Capital Pro-Égaux Inc.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890